HUT69400A - Pharmaceutical compositions containing nonionic surfractants - Google Patents
Pharmaceutical compositions containing nonionic surfractants Download PDFInfo
- Publication number
- HUT69400A HUT69400A HU9302774A HU9302774A HUT69400A HU T69400 A HUT69400 A HU T69400A HU 9302774 A HU9302774 A HU 9302774A HU 9302774 A HU9302774 A HU 9302774A HU T69400 A HUT69400 A HU T69400A
- Authority
- HU
- Hungary
- Prior art keywords
- active agent
- nonionic surfactant
- composition
- polyoxyethylene
- ethoxylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95596292A | 1992-10-02 | 1992-10-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9302774D0 HU9302774D0 (en) | 1993-12-28 |
| HUT69400A true HUT69400A (en) | 1995-09-28 |
Family
ID=25497602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9302774A HUT69400A (en) | 1992-10-02 | 1993-09-30 | Pharmaceutical compositions containing nonionic surfractants |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0662826A1 (zh) |
| JP (1) | JPH07507565A (zh) |
| KR (1) | KR950703333A (zh) |
| AU (1) | AU5095393A (zh) |
| CA (1) | CA2145763A1 (zh) |
| FI (1) | FI934317A (zh) |
| HU (1) | HUT69400A (zh) |
| IL (1) | IL107084A0 (zh) |
| MX (1) | MX9306125A (zh) |
| TW (1) | TW253838B (zh) |
| WO (1) | WO1994007472A1 (zh) |
| ZA (1) | ZA937268B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1808897A (en) * | 1995-12-13 | 1997-07-03 | Dullatur Limited | A calcitonin preparation |
| SE9602145D0 (sv) * | 1996-05-31 | 1996-05-31 | Astra Ab | New improved formulation for treatment of thromboembolism |
| KR101390695B1 (ko) * | 2006-08-01 | 2014-04-30 | 오츠카 세이야쿠 가부시키가이샤 | 약리 활성 물질의 흡수성이 개선된 의약 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
| JPS6233128A (ja) * | 1985-08-07 | 1987-02-13 | Toray Ind Inc | インタ−フエロン腸溶性経口用製剤 |
| ES2045276T3 (es) * | 1988-07-21 | 1994-01-16 | Hoffmann La Roche | Preparacion de insulina |
| EP0498361A3 (en) * | 1991-02-06 | 1992-09-02 | Schering Corporation | Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| JPH06510796A (ja) * | 1991-12-18 | 1994-12-01 | ファイザー インク． | 酵素による不活性化から生物活性ペプチドを保護するための医薬組成物におけるダイズタンパク質又は加水分解物 |
-
1993
- 1993-09-02 JP JP6509047A patent/JPH07507565A/ja active Pending
- 1993-09-02 AU AU50953/93A patent/AU5095393A/en not_active Abandoned
- 1993-09-02 KR KR1019950701257A patent/KR950703333A/ko not_active Application Discontinuation
- 1993-09-02 EP EP93920391A patent/EP0662826A1/en not_active Withdrawn
- 1993-09-02 CA CA002145763A patent/CA2145763A1/en not_active Abandoned
- 1993-09-02 WO PCT/US1993/008107 patent/WO1994007472A1/en not_active Application Discontinuation
- 1993-09-10 TW TW082107450A patent/TW253838B/zh active
- 1993-09-23 IL IL107084A patent/IL107084A0/xx unknown
- 1993-09-30 ZA ZA937268A patent/ZA937268B/xx unknown
- 1993-09-30 HU HU9302774A patent/HUT69400A/hu unknown
- 1993-10-01 FI FI934317A patent/FI934317A/fi not_active Application Discontinuation
- 1993-10-01 MX MX9306125A patent/MX9306125A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9302774D0 (en) | 1993-12-28 |
| FI934317A0 (fi) | 1993-10-01 |
| FI934317A (fi) | 1994-04-03 |
| WO1994007472A1 (en) | 1994-04-14 |
| EP0662826A1 (en) | 1995-07-19 |
| ZA937268B (en) | 1995-03-30 |
| AU5095393A (en) | 1994-04-26 |
| IL107084A0 (en) | 1993-12-28 |
| CA2145763A1 (en) | 1994-04-14 |
| JPH07507565A (ja) | 1995-08-24 |
| MX9306125A (es) | 1994-04-29 |
| KR950703333A (ko) | 1995-09-20 |
| TW253838B (zh) | 1995-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU617157B2 (en) | Intravaginal delivery of biologically active polypeptides | |
| KR100498646B1 (ko) | 경구용 펩티드 약학적 조성물 | |
| JP5100334B2 (ja) | カプセル封入されたドラッグデリバリー用透明液 | |
| KR100602725B1 (ko) | 물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물 | |
| JP5671451B2 (ja) | ＧｎＲＨ関連化合物の組成物および調製プロセス | |
| EP0387352B1 (en) | Enteric formulations of physiologically active peptides and proteins | |
| WO1994008605A1 (en) | Therapeutic microemulsions | |
| KR100620292B1 (ko) | 액체 제형물을 포함하는 제형 | |
| EP1575555B1 (en) | Formulations of finasteride | |
| HUT75252A (en) | Oral pharmaceutical compositions | |
| JPH10139661A (ja) | 新規な治療用抗炎症鎮痛医薬組成物およびその製造法 | |
| JP3181062B2 (ja) | 下部消化管崩壊経口製剤 | |
| HUT69400A (en) | Pharmaceutical compositions containing nonionic surfractants | |
| JP2022526833A (ja) | 浸透性が低いタンパク質、ペプチド、及び小分子の経口送達用の製剤 | |
| JP2006056781A (ja) | 界面活性剤を含む固形化製剤 | |
| US6979672B2 (en) | Cyclosporin-based pharmaceutical compositions | |
| KR100341203B1 (ko) | 유성 비타민 함유 약학 조성물 및 이의 제조방법 | |
| CN113784722B (zh) | 用于有不良渗透性的蛋白质、肽和小分子的口服递送的制剂 | |
| WO1995006463A1 (en) | Pharmaceutical compositions containing anionic surfactants | |
| EA046567B1 (ru) | Композиция для пероральной доставки гидрофильных синтетических или природных молекул со слабой проницаемостью | |
| JPH0764755B2 (ja) | 経粘膜投与用組成物 | |
| JPH0510329B2 (zh) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |